Yogiman的个人主页 - 老虎社区

Yogiman

Yogiman

暂无个人介绍

IP属地：未知

4关注

0粉丝

0主题

0勋章

2021-08-13

Lemonade go for it

2 Tech Stocks With 96% to 140% Upside, According to Wall Street

2021-07-30

Too expensive

Wall Street analysts react to Amazon’s disappointing second-quarter earnings

2021-07-30

Worrying 😟

Goldman Sachs has been super-bullish on the global economy, but not anymore. Here's why.

2021-07-20

Will market crash?

Inflation Is Here — These 35 Metrics Tell You How Much to Worry

2021-07-19

Inflation worries ahead ....

抱歉，原内容已删除

2021-07-17

Yeah true[笑哭]

U.S. to allow temporary rise in impurities in anti-smoking drug

2021-07-17

Will it affect share price

Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content

2021-07-16

Should have more details

抱歉，原内容已删除

2021-07-16

Nice to read article

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4089547899638310","uuid":"4089547899638310","gmtCreate":1626447708603,"gmtModify":1626487441380,"name":"Yogiman","pinyin":"yogiman","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":4,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.28","exceedPercentage":"60.31%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.28","exceedPercentage":"93.37%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":897077805,"gmtCreate":1628865581207,"gmtModify":1631884033650,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Lemonade go for&nbsp; it","listText":"Lemonade go for&nbsp; it","text":"Lemonade go for it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/897077805","repostId":"2159291893","repostType":4,"repost":{"id":"2159291893","kind":"highlight","pubTimestamp":1628864400,"share":"https://ttm.financial/m/news/2159291893?lang=&edition=full","pubTime":"2021-08-13 22:20","market":"us","language":"en","title":"2 Tech Stocks With 96% to 140% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2159291893","media":"Motley Fool","summary":"Analysts see big gains for Coinbase and Lemonade shareholders.","content":"<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.</p>\n<p>With that in mind, Wall Street analysts see significant upside for&nbsp;<b>Coinbase Global</b> (NASDAQ:COIN) and&nbsp;<b>Lemonade</b> (NYSE:LMND). Let's look at both of these tech stocks.</p>\n<h2>Coinbase Global: 140% implied upside</h2>\n<p>Coinbase helps its clients participate in the cryptoeconomy. Its platform offers a range&nbsp;of products to 68 million&nbsp;users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.</p>\n<p>For instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.</p>\n<p>As of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2%&nbsp;of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson&nbsp;value Coinbase stock at $650 per share, a 140% premium to its current price.</p>\n<p>Financially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees&nbsp;comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price&nbsp;of <b>bitcoin</b> and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2020 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Monthly transacting users</p></td>\n   <td width=\"156\"><p>1.5 million</p></td>\n   <td width=\"156\"><p>8.8 million</p></td>\n   <td width=\"156\"><p>487%</p></td>\n  </tr>\n  <tr>\n   <td width=\"156\"><p>Revenue</p></td>\n   <td width=\"156\"><p>$633.8 million</p></td>\n   <td width=\"156\"><p>$4.9 billion</p></td>\n   <td width=\"156\"><p>678%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Coinbase&nbsp;SEC filings. TTM&nbsp;= trailing-12-months. CAGR&nbsp;= compound annual growth rates.</p>\n<p>Before buying Coinbase stock, investors should ask themselves <a href=\"https://laohu8.com/S/AONE.U\">one</a> question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.</p>\n<h2>Lemonade: 96% implied upside</h2>\n<p>Lemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.</p>\n<p>This differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built&nbsp;to collect and deploy the types of data captured by Lemonade.</p>\n<p>This advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler&nbsp;value Lemonade at $163 per share, representing 96% upside compared to its current price.</p>\n<p>Investors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2019 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Customers</p></td>\n   <td width=\"156\"><p>442,752</p></td>\n   <td width=\"156\"><p>1.2 million</p></td>\n   <td width=\"156\"><p>65%</p></td>\n  </tr>\n  <tr>\n   <td width=\"156\"><p>Gross profit</p></td>\n   <td width=\"156\"><p>$5.7 million</p></td>\n   <td width=\"156\"><p>$26.5 million</p></td>\n   <td width=\"156\"><p>116%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.</p>\n<p>Looking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Tech Stocks With 96% to 140% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Tech Stocks With 96% to 140% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 22:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LMND":"Lemonade, Inc.","COIN":"Coinbase Global, Inc."},"source_url":"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159291893","content_text":"As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.\nWith that in mind, Wall Street analysts see significant upside for Coinbase Global (NASDAQ:COIN) and Lemonade (NYSE:LMND). Let's look at both of these tech stocks.\nCoinbase Global: 140% implied upside\nCoinbase helps its clients participate in the cryptoeconomy. Its platform offers a range of products to 68 million users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.\nFor instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.\nAs of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2% of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson value Coinbase stock at $650 per share, a 140% premium to its current price.\nFinancially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price of bitcoin and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.\n\n\n\nMetric\nQ2 2020 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nMonthly transacting users\n1.5 million\n8.8 million\n487%\n\n\nRevenue\n$633.8 million\n$4.9 billion\n678%\n\n\n\nData source: Coinbase SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rates.\nBefore buying Coinbase stock, investors should ask themselves one question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.\nLemonade: 96% implied upside\nLemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.\nThis differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built to collect and deploy the types of data captured by Lemonade.\nThis advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler value Lemonade at $163 per share, representing 96% upside compared to its current price.\nInvestors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.\n\n\n\nMetric\nQ2 2019 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nCustomers\n442,752\n1.2 million\n65%\n\n\nGross profit\n$5.7 million\n$26.5 million\n116%\n\n\n\nData source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.\nLooking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.","news_type":1,"symbols_score_info":{"COIN":0.9,"LMND":0.9}},"isVote":1,"tweetType":1,"viewCount":781,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806845452,"gmtCreate":1627651505676,"gmtModify":1633757435529,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Too expensive","listText":"Too expensive","text":"Too expensive","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806845452","repostId":"1161272388","repostType":4,"repost":{"id":"1161272388","kind":"news","pubTimestamp":1627644776,"share":"https://ttm.financial/m/news/1161272388?lang=&edition=full","pubTime":"2021-07-30 19:32","market":"us","language":"en","title":"Wall Street analysts react to Amazon’s disappointing second-quarter earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1161272388","media":"CNBC","summary":"Amazon reported another massive quarter on Thursday, but it wasn’t enough to meet sky-high expectations, leading Wall Street analysts to scale back their estimates.The tech giant reported $15.12 in earnings per share and $113.08 billion in revenue for its second quarter. That topped expectations of $12.30 in earnings but missed the projected $115.2 billion in revenue, according to analysts surveyed by Refinitiv.Following the report, Morgan Stanley’s Brian Nowak cut his price target for the stock","content":"<div>\n<p>Amazon reported another massive quarter on Thursday, but it wasn’t enough to meet sky-high expectations, leading Wall Street analysts to scale back their estimates.\nThe tech giant reported $15.12 in ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/30/amazon-earnings-wall-street-analysts-react.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street analysts react to Amazon’s disappointing second-quarter earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street analysts react to Amazon’s disappointing second-quarter earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-30 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/30/amazon-earnings-wall-street-analysts-react.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amazon reported another massive quarter on Thursday, but it wasn’t enough to meet sky-high expectations, leading Wall Street analysts to scale back their estimates.\nThe tech giant reported $15.12 in ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/30/amazon-earnings-wall-street-analysts-react.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://www.cnbc.com/2021/07/30/amazon-earnings-wall-street-analysts-react.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1161272388","content_text":"Amazon reported another massive quarter on Thursday, but it wasn’t enough to meet sky-high expectations, leading Wall Street analysts to scale back their estimates.\nThe tech giant reported $15.12 in earnings per share and $113.08 billion in revenue for its second quarter. That topped expectations of $12.30 in earnings but missed the projected $115.2 billion in revenue, according to analysts surveyed by Refinitiv.\nFollowing the report, Morgan Stanley’s Brian Nowak cut his price target for the stock to $4,300 per share from $4,500, citing the potential for some near-term weakness. However, Nowak did keep his overweight rating on the stock and said the long-term outlook was strong.\nAmazon closed Thursday at $3,599.92, off 0.8% for the session, and fell another 6.3% in premarket trading Friday.\n“AMZN’s slower than expected retail revenue growth and lower profitability (from surging investment) send estimates lower today. Over the long-term we see these investments leading to deeper core retail and AWS moats (why we remain bullish),” the Morgan Stanley note said.\nSimilarly, UBS analyst Michael Lasser lowered his price target on Amazon to $4,020 per share from $4,350 but reiterated his buy rating.\n“In the past, it’s been prudent to accumulate AMZN’s shares when they pull back in response to an investment cycle. We think it would be shrewd to do the same now. We are moderating our EPS [estimates] due to slightly lower NT rev assumptions & ongoing investments in fulfillment. But, these should payoff over the long-run,” the UBS note said.\nHere’s what analysts said about Amazon earnings:\nAtlantic Equities - Overweight, price target to $3,800 from $4,000\n\n “Q2 revenue missed and Q3 revenue and op profit guidance were below consensus as reopenings slowed Amazon’s sales growth more than anticipated, with the lower top line reducing leverage. On the flipside, AWS delivered an impressive acceleration and advertising topped expectations, and with both these key profit drivers remaining strong we continue to see attractive profit growth in 2022, albeit are reducing our projections slightly.”\n\nMizuho - Buy, price target to $4,100 from $4,400\n\n “With expectations being reset, we are lowering FY23 EBITDA by 6% to $130bn and PT from $4,400 to $4,100, but we feel 3Q21 revenue guidance could be conservative due to the return of back-to-school. We remain positive on AMZN long-term, and believe its valuation is attractive at 13x FY23 EBITDA compared to 30% CAGR.”\n\nBarclays - Overweight, price target to $4,130 from $4,300\n\n “AMZN reported revenue and OI that were 2% and 1% below consensus and guided 3Q below. This kind of miss is a rare occurrence for a high quality name like AMZN, but forecasting the back side of the pandemic surge is proving challenging for many companies, and despite the deceleration, AMZN continues to add prime members and gain e-commerce share. This print won’t derail the long-term bull case around AWS and retail, but likely means we are range bound for the next few months until a catalyst emerges.”\n\nBank of America - Buy, price target to $4,250 from $4,350\n\n “We think results suggest bigger slowdown in May/June Online retail spend than expected (negative read for eBay/Wayfair), while 3Q revenue guidance miss partially reflects Street not properly incorporating Prime Day shift impact on 3Q. ... . Amazon stock was down as much as 7% in AH trading, likely on the disappointing revenue guide and possibly AWS margins, but we think company remains in solid position in industry, with US retail growth above our industry sales.′\n\nEvercore ISI - Outperform, price target to $4,200 from $4,500\n\n “Our long term thesis is intact for Amazon. ... .Tactically, AMZN shares may well be range bound near-term as investors debate whether AMZN can recover to 20% reported Y/Y revenue growth in 2022 – we believe it can, given the size of its TAMs, its new growth initiatives, and its execution track record. Investors will also debate the potential ROI on Amazon’s latest investment cycle – i.e. its declining Operating Margins in H2:21.”\n\nCredit Suisse - Outperform, price target to $4,700 from $4,850\n\n “We maintain our Outperform rating for AMZN shares on the following points: 1) continued e-commerce segment operating margin expansion as Amazon grows into its larger infrastructure, 2) optionality for faster-than-expected FCF growth vis-à-vis its advertising segment, 3) upward bias to AWS revenue forecasts and likely more moderate deceleration path as suggested by ongoing capital intensity and rising performance obligations.”\n\nJPMorgan - Overweight, price target to $4,100 from $4,600\n\n “Slower growth & increased investments make the shares more challenging NT, but we expect revenue growth to normalize more around 20% next year & AMZN’s investments in fulfillment & logistics bode well for future growth, including for AMZL & MCF (multi-channel fulfillment).”\n\nJefferies- Buy, $4,200 price target\n\n “AMZN’s highest margin businesses accelerated once again in 2Q, while core-Retail decelerated from difficult comps and increased mobility. Despite 3Q revenue guidance coming in below consensus, our revised estimates imply core-Retail growth will remain above pre-pandemic levels on a 2-year basis.”\n\nJMP - Market outperform, $4,500 price target\n\n “We acknowledge the concern around decelerating growth as markets reopen and comps get tougher throughout the year. But we also believe that consumer behavior changes toward eCommerce due to the pandemic are lasting and that given the continued health of the consumer (at least domestically), Amazon remains among the best-positioned providers overall. We were encouraged with AWS and Amazon Advertising revenue reaccelerating in the quarter, trends that could continue, and we reiterate our Market Outperform rating and $4,500 price target.”\n\nKeyBanc - Overweight, $4,000 price target\n\n “Amazon.com will have been one of the strongest beneficiaries of COVID driven secular acceleration, but we believe reopening will drive lumpiness in growth rates. Nevertheless, Prime Member spending is still up y/y and overall competitive dynamics remain more favorable than pre-COVID. +37% AWS growth was strong and corporates focusing on growth investments should be a tailwind. We remain OW-rated given strong long-term share (and earnings) opportunities.”\n\nBaird - Outperform, $4,000 price target\n\n “We never like to see a miss, especially after shares outperformed since Q1, but it’s not shocking given choppy Q2 e-commerce checks (keep in mind results were in line with guidance.) What’s more notable, in our view, than the impact of mobility is that each of Amazon’s key (higher margin) services segments beat consensus expectations: AWS, 3P Services, Subscriptions, and Advertising. This is the quasi-recurring model we’ve highlighted as deserving of a higher multiple.”\n\nPiper Sandler - Overweight, price target to $3,904 from $4,000\n\n “Less positive, management noted online shopping behavior has changed with consumers comp-ing last year’s demand plus greater mobility. Management said to expect the pattern of difficult y/y revenue compares to continue for the next several quarters. Further, management alluded to the recent pullforward in demand requiring additional investment to catch up. ... .Essentially, while consumer demand has waned with the pandemic, investment remains elevated.”\n\nStifel - Buy, $4,400 price target\n\n “We now have better visibility into the 2H and estimates are adjusted better reflecting the new normal as we emerge from the pandemic. We believe the setup is attractive now that the shares are on the other side of the COVID comp reset. We would be buyers on the share decline stemming from tonight’s report and maintain our $4,400 price target.”\n\nCowen - Outperform, price target to $4,400 from $4,600\n\n “AMZN’s 2Q21 results were softer than expected, with rev 1.8% below consensus as higher consumer mobility impacted eCommerce demand, muting further acceleration at AWS and adv.; Op Income was also 1% below cons. Meanwhile, 3Q21 rev and Op Inc. guide were below cons. on tougher eCommerce comps & higher fulfillment costs.”\n\nTruist - Buy, price target to $3,800 from $4,000\n\n “2Q21 marks Amazon’s first earnings miss since the start of the pandemic, reflecting a mixed picture of softening demand within its Online Stores segment but sustained strength across AWS, 3P and advertising, which drove improved margins. While ecom demand may be normalizing with the re-opening, we still expect AMZN to put up mid-teens growth against a tough +40% in 2H20, with re-acceleration in FY22.”\n\nOppenheimer - Outperform, price target to $4,200 from $4,400\n\n “While reducing our target to $4,200 from $4,400 on expected slower 2H growth, we are maintaining our Outperform rating, given the prospects for secular gains ahead of AMZN. ... .While slowing in 2Q, growth in high margin segments continued to outpace growth in the overall business, leaving room for profitability upside in 2H.”\n\nGuggenheim - Buy, $4,200 price target\n\n “We continue to believe Amazon is very well positioned for the long term and reiterate our BUY rating and $4,200 price target. We would buy the weakness in the shares.While the company noted a moderation in its year-over-year growth rate during 2Q21 into the mid-teens and the company will continue to be up against difficult top-line comparisons in coming quarters, we continue to see a favorable backdrop for the company and the shares through the balance of 2021 as top-line growth should remain healthy, but decelerating.”\n\nTelsey - Outperform, $4,000 price target\n\n “We understand Amazon shares are likely to trade down, given soft 2Q21 results and a lower 3Q21 outlook. That said, we believe Amazon is executing at a high level and should continue to gain market share by leveraging its sticky customer base, small business relationships, and retail consolidation. The focus on newer businesses and initiatives—grocery, pharmacy, fashion, home, private brands, third-party, same-day/one-day delivery, and Amazon Logistics—is making Amazon more valuable.”\n\nBernstein - Outperform, price target to $4,000 from $4,200\n\n “At some point, when you’re 40% of US eCommerce and7-8% of US retail, it’s harder to create beta beyond overall retail trends. ... The revenue and EBIT guide were also lower than anticipated, reminding everyone that Amazon is still very much a retail-first business.”\n\nNeedham - Buy, $4,150 price target\n\n “AMZN is a services company, not a products company (our view) because Services revs reached 49% of 2Q revs, and we calculate that Services segment profit was $10.7B, which was 4x higher than Product profits in 2Q21. We expect Services revs to be larger than Product revs in 3Q21.”","news_type":1,"symbols_score_info":{"AMZN":0.9}},"isVote":1,"tweetType":1,"viewCount":496,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806846344,"gmtCreate":1627651396688,"gmtModify":1633757437507,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Worrying 😟","listText":"Worrying 😟","text":"Worrying 😟","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806846344","repostId":"2155137729","repostType":4,"repost":{"id":"2155137729","kind":"highlight","pubTimestamp":1627647756,"share":"https://ttm.financial/m/news/2155137729?lang=&edition=full","pubTime":"2021-07-30 20:22","market":"us","language":"en","title":"Goldman Sachs has been super-bullish on the global economy, but not anymore. Here's why.","url":"https://stock-news.laohu8.com/highlight/detail?id=2155137729","media":"MarketWatch","summary":"Goldman Sachs has prided itself on its bullish stance on the global economy, with its above-consensu","content":"<p>Goldman Sachs has prided itself on its bullish stance on the global economy, with its above-consensus takes doing better than many of its banking rivals to forecast just how resilient consumers and businesses have been.</p>\n<p>The gross domestic product data released Thursday show the world's largest economy, the U.S., has already surpassed its pre-pandemic peak in the second quarter.</p>\n<p>But...</p>\n<p>Goldman Sachs economists Daan Struyven and Sid Bhushan explain the bank's economics team has now become less enthusiastic. They've cut economic growth projections for the low-vaccination Asian economies including India and Australia but also the U.S. -- even while upgrading Brazil and Mexico forecasts -- taking their global growth forecast for this year to 6.4%, which is only 0.3% above the Wall Street consensus.</p>\n<p><img src=\"https://static.tigerbbs.com/efafcbb409cc58c4236521501a1f3e8f\" tg-width=\"700\" tg-height=\"341\" width=\"100%\" height=\"auto\"></p>\n<p>The more transmissible delta strain of coronavirus implies a slower recovery because of renewed outbreaks. The issue isn't just government restrictions, but also the choices of individuals to limit high-contact services.</p>\n<p>\"The share of Americans reporting to 'always avoid' high-contact activities has decreased, but remains substantial at around 50% for public transportation and large events, and 30% for travel,\" they said, citing YouGov data. \"A further recovery will require not only rising vaccinations and related medical improvements, but also time for individuals to become more comfortable.\"</p>\n<p><img src=\"https://static.tigerbbs.com/72d09db3e3c3223ebe3f95b0d81180af\" tg-width=\"700\" tg-height=\"465\" width=\"100%\" height=\"auto\"></p>\n<p>And the U.S. is grouped into <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the low-risk aversion countries, based on the restrictions imposed relative to fatalities. \"China's high risk aversion could keep quarantines and travel controls in place for longer, and delay the recovery in tourism economies such as Vietnam, Thailand, and Singapore,\" they say.</p>\n<p>The pessimism comes amid a new report from the Centers for Disease Control and Prevention, arguing the delta variant as as transmissible as chickenpox.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs has been super-bullish on the global economy, but not anymore. Here's why.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs has been super-bullish on the global economy, but not anymore. Here's why.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-30 20:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/goldman-sachs-has-been-super-bullish-on-the-global-economy-but-not-anymore-heres-why-11627641051?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has prided itself on its bullish stance on the global economy, with its above-consensus takes doing better than many of its banking rivals to forecast just how resilient consumers and ...</p>\n\n<a href=\"https://www.marketwatch.com/story/goldman-sachs-has-been-super-bullish-on-the-global-economy-but-not-anymore-heres-why-11627641051?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.marketwatch.com/story/goldman-sachs-has-been-super-bullish-on-the-global-economy-but-not-anymore-heres-why-11627641051?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155137729","content_text":"Goldman Sachs has prided itself on its bullish stance on the global economy, with its above-consensus takes doing better than many of its banking rivals to forecast just how resilient consumers and businesses have been.\nThe gross domestic product data released Thursday show the world's largest economy, the U.S., has already surpassed its pre-pandemic peak in the second quarter.\nBut...\nGoldman Sachs economists Daan Struyven and Sid Bhushan explain the bank's economics team has now become less enthusiastic. They've cut economic growth projections for the low-vaccination Asian economies including India and Australia but also the U.S. -- even while upgrading Brazil and Mexico forecasts -- taking their global growth forecast for this year to 6.4%, which is only 0.3% above the Wall Street consensus.\n\nThe more transmissible delta strain of coronavirus implies a slower recovery because of renewed outbreaks. The issue isn't just government restrictions, but also the choices of individuals to limit high-contact services.\n\"The share of Americans reporting to 'always avoid' high-contact activities has decreased, but remains substantial at around 50% for public transportation and large events, and 30% for travel,\" they said, citing YouGov data. \"A further recovery will require not only rising vaccinations and related medical improvements, but also time for individuals to become more comfortable.\"\n\nAnd the U.S. is grouped into one of the low-risk aversion countries, based on the restrictions imposed relative to fatalities. \"China's high risk aversion could keep quarantines and travel controls in place for longer, and delay the recovery in tourism economies such as Vietnam, Thailand, and Singapore,\" they say.\nThe pessimism comes amid a new report from the Centers for Disease Control and Prevention, arguing the delta variant as as transmissible as chickenpox.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":983,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171713003,"gmtCreate":1626763657102,"gmtModify":1633771248774,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Will market crash?","listText":"Will market crash?","text":"Will market crash?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171713003","repostId":"1140799023","repostType":4,"repost":{"id":"1140799023","kind":"news","pubTimestamp":1626759279,"share":"https://ttm.financial/m/news/1140799023?lang=&edition=full","pubTime":"2021-07-20 13:34","market":"hk","language":"en","title":"Inflation Is Here — These 35 Metrics Tell You How Much to Worry","url":"https://stock-news.laohu8.com/highlight/detail?id=1140799023","media":"Bloomberg","summary":"A year ago, the Covid-19 pandemic crushed prices in many parts of the U.S. economy. As expected, tha","content":"<p>A year ago, the Covid-19 pandemic crushed prices in many parts of the U.S. economy. As expected, that has created inflation 12 months on as the economy reopens and rebounds. Now the market seems to believe that a resurgence of the pandemic will rein in inflation before it grows out of control. No one disputes that inflation has arrived. The question is where it’s heading.</p>\n<p>The most basic fact is that June’s “headline” consumer price index, including everything the government puts in its representative basket of products and services that Americans buy, stands at 5.4%, the highest in 30 years barring one month in the summer of 2008 when oil reached nearly $150 per barrel. Exclude food and fuel, always variable, and inflation still comes in at 4.5% — its highest in three decades by far. Even if the most extreme movers both up and down are stripped out, inflation stands at 2.9%, its worst since 1992 (barring a few months of very expensive oil). Those numbers would seem to validate the doomsayers.</p>\n<p>Yet bond markets and economists take the opposite view. They see inflation not only coming under control but eventually falling to levels lower than before the pandemic hit. The bond market’s best estimate of the average inflation rate for the next 10 years stands at 2.3%, which is roughly where it’s been for four months even as other numbers have gotten worse. The yield curve — the extra yield that investors demand for 10-year bonds rather than 2-year bonds, which generally rises when people expect higher inflation — is now below 1%. That’s less than its average for the last decade, a period when inflation hasn’t been a problem. Indeed, it’s no higher than it was in February.</p>\n<p>Either market players remain confident that the Federal Reserve can keep rising prices under control, or they’re worried the economy won’t keep growing fast enough to push inflation numbers higher. Those concerns are definitely increasing as the delta variant shows its ability to slow economic reopening.</p>\n<p>Our dashboard of indicators aims to add clarity to this debate. Inflation is a complex phenomenon that grows from many places. These 35 key measures offer up a more nuanced picture of how markets are positioned, what the official data say and what consumers and businesses are discounting. Numbers are current as of Monday, July 19 and will be updated weekly.</p>\n<p><img src=\"https://static.tigerbbs.com/adee36e07b6919f5636c61bcddc3afcb\" tg-width=\"949\" tg-height=\"678\" referrerpolicy=\"no-referrer\">Flashing alarmingly bright are the official data, as well as surveys of businesses and consumers. The latest survey by the National Federation of Independent Business, of prices paid by small companies, is at a level it last reached all the way back in the first quarter of 1981. Yet showing no concern at all are market indicators and Bloomberg’s surveys of expert economists’ predictions. Both are below their averages for the last decade.</p>\n<p>Resolution should come in two categories that remain finely balanced: prices and wages. These factors drove inflation higher in the 1970s and could do so again. Prices of futures for oil, agriculture and metals have all given up ground after rising very sharply from last year’s lows. But the raw industrials index, which includes basic commodities that aren’t in the futures markets, continues to rise and is nearing its historic top from more than a decade ago.</p>\n<p>Meanwhile, although wage growth remains well within its recent ranges, the pay of low-skilled workers is picking up and employers are complaining that they cannot fill jobs, which could imply wage inflation ahead. The decisive factor could be if a new pandemic-related downturn weakens demand, as well as the hand of labor, again. That would be bad news, but at least it would avert an extended bout of inflation.</p>\n<p><img src=\"https://static.tigerbbs.com/5e71f075b43fcaeb158fd768e81345b8\" tg-width=\"944\" tg-height=\"377\" referrerpolicy=\"no-referrer\">June’s inflation data delivered a third nasty shock in succession. The Fed’s preferred measure of inflation, the Core PCE deflator, is also at its highest level since 1992. Meanwhile, headline inflation (including fuel and food) is at 5% for the first time since the oil price spike of 2008. Producer price inflation is also high. These are sudden moves and the more muted rise in the “trimmed mean” measure, which excludes goods that have suffered the most extreme changes in price, suggests that it is indeed mainly a transitory effect from the pandemic. But it will still be a relief if next month’s data can show a significant retreat in some of the sectors that were hit by extreme inflation.</p>\n<p><img src=\"https://static.tigerbbs.com/03f56e14f20907601eea311f677649c5\" tg-width=\"954\" tg-height=\"371\" referrerpolicy=\"no-referrer\">There is deepening concern over shelter inflation, the single biggest component of the CPI index, which is now up to 2.3% and will likely rise further as higher house prices pull up rents in their wake. This will be particularly closely watched. But the most extreme transitory effects of the pandemic are otherwise beginning to ease. Car rental prices, for example, are now “only” 88% higher than they were 12 months ago, having previously topped 100%.&nbsp;Several sectors which suffered a deflationary blow from the pandemic are still not seeing prices recover. Recreation inflation is still negative. And — heaven be praised — college-tuition inflation remains close to its lowest since records began in 1979, although it did tick up slightly in June. It is still just about possible to sustain an optimistic narrative that the pandemic caused extraordinary inflation in some pockets of the economy but might have brought sanity to others where prices had grown prohibitive.</p>\n<p><img src=\"https://static.tigerbbs.com/eacb4482c44ce01dc5be1582e8932f5a\" tg-width=\"948\" tg-height=\"375\" referrerpolicy=\"no-referrer\">The bond market, where traders make their most precise predictions of inflation, has been in flux all year. Four months ago, 5-year breakevens topped 2.75%, virtually matching their high during the 2008 oil price spike. Since then they have dropped below 2.4%, although the latest data returned them to 2.6% — higher than they were at any point between 2010 and 2020. Meanwhile, expectations for the years from 2026 to 2031 have fallen to 2.16%, suggesting confidence that the Fed will be able to rein in inflation over the next five years. The heat map is based on the 20-day moving average of the breakevens, to avoid being too affected by day-to-day movements, which have been violent in the last few weeks. Nobody is positioned for the Fed to lose control of inflation anytime soon, nor for Germany or Japan to snap out of their disinflationary malaise.</p>\n<p><img src=\"https://static.tigerbbs.com/e052d83b8f96767e4b22170b4455ffd8\" tg-width=\"943\" tg-height=\"373\" referrerpolicy=\"no-referrer\">These numbers offer perhaps the greatest support for the case that inflation is a near and present danger. All are way above their ranges for the last decade. The small business survey shows inflation expectations at their highest in four decades, while the Institute for Supply Management numbers are at post-2008 highs&nbsp;and still rising in the latest number produced at the beginning of July — although the survey for the services sector did show a slight decline. Consumer expectations have also risen very sharply, to their highest since the commodity price spike before the financial crisis, with the latest Conference Board survey reaching a fresh high for this cycle. This could be transitory but, if so, the numbers need to come down soon.</p>\n<p><img src=\"https://static.tigerbbs.com/503a1ccabd574d899752b5acb9d3900b\" tg-width=\"948\" tg-height=\"379\" referrerpolicy=\"no-referrer\"></p>\n<p>Rising commodity prices represent exactly the kind of inflation that can attack living standards. But, given the economic collapse a year ago and the rush by speculators to get a leveraged play on the rebound, they don’t give firm evidence of inflation that is more than transitory. Metals prices are about 6% below their May peak, while energy prices have also dropped by about 6% as the OPEC+ cartel tries to sort out its problems; it’s not at all clear the latter are locked into an inflationary expansion. One increasingly ominous warning sign comes from the Commodities Research Board raw industrials index, which covers basic commodities that aren’t in the futures market. In theory, these prices should be driven by supply-and-demand dynamics in the real world, not by ebbs and flows of emotion in the markets. The index has gained more than 50% in a year and is nearing an all-time high.</p>\n<p><img src=\"https://static.tigerbbs.com/037e6afcf827db9373c9fa59e7d762f7\" tg-width=\"954\" tg-height=\"381\" referrerpolicy=\"no-referrer\"></p>\n<p>Wage inflation is a crucial driver of inflation and, from the official data, it appears to be under control despite a number of factors that would normally drive salaries and wages upwards. Most measures of wage inflation are running below their average for the last five years, with the Atlanta Fed putting overall wage growth at 3.2%. Yet, job vacancies are at an all-time record, while small businesses complain that they have never found it harder to recruit workers. This suggests a problem with skill mismatches coming out of the recession. At the same time, while average hourly earnings have been quite variable over the last few months, the latest number shows them increasing at the fastest rate since 2009. The ongoing wage tracker kept by the Atlanta Fed shows that wage inflation for low-skilled workers has reached 3.6%, close to its highest since the global financial crisis. The National Federation of Independent Business finds the highest proportion of its members raising pay since they started asking the question in 1984.</p>\n<p><img src=\"https://static.tigerbbs.com/fbee8b94aaefef4fa3e232c198af27cd\" tg-width=\"951\" tg-height=\"394\" referrerpolicy=\"no-referrer\"></p>\n<p>Broadly, the consensus is that the Fed, like other central banks, will get what it wants. The Fed is forecasting Core PCE (personal consumption expenditure) of 3% for this year but expects it to decline to 2% in 2023; in other words, it will be transitory. The experts are less anxious for now and think it will reach 2.5% this year and decline in the two following years — more or less perfect for the Fed, which is prepared to let inflation “run hot.” German inflation, after a bobble this year, is expected to fall back to 1.7% in 2023; there’s no sign of a new reflationary cycle there or in Japan, or even China. Whatever markets say, the experts are still more worried about deflation.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inflation Is Here — These 35 Metrics Tell You How Much to Worry</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInflation Is Here — These 35 Metrics Tell You How Much to Worry\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-20 13:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/graphics/opinion-authers-inflation-tracker/?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A year ago, the Covid-19 pandemic crushed prices in many parts of the U.S. economy. As expected, that has created inflation 12 months on as the economy reopens and rebounds. Now the market seems to ...</p>\n\n<a href=\"https://www.bloomberg.com/graphics/opinion-authers-inflation-tracker/?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.bloomberg.com/graphics/opinion-authers-inflation-tracker/?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140799023","content_text":"A year ago, the Covid-19 pandemic crushed prices in many parts of the U.S. economy. As expected, that has created inflation 12 months on as the economy reopens and rebounds. Now the market seems to believe that a resurgence of the pandemic will rein in inflation before it grows out of control. No one disputes that inflation has arrived. The question is where it’s heading.\nThe most basic fact is that June’s “headline” consumer price index, including everything the government puts in its representative basket of products and services that Americans buy, stands at 5.4%, the highest in 30 years barring one month in the summer of 2008 when oil reached nearly $150 per barrel. Exclude food and fuel, always variable, and inflation still comes in at 4.5% — its highest in three decades by far. Even if the most extreme movers both up and down are stripped out, inflation stands at 2.9%, its worst since 1992 (barring a few months of very expensive oil). Those numbers would seem to validate the doomsayers.\nYet bond markets and economists take the opposite view. They see inflation not only coming under control but eventually falling to levels lower than before the pandemic hit. The bond market’s best estimate of the average inflation rate for the next 10 years stands at 2.3%, which is roughly where it’s been for four months even as other numbers have gotten worse. The yield curve — the extra yield that investors demand for 10-year bonds rather than 2-year bonds, which generally rises when people expect higher inflation — is now below 1%. That’s less than its average for the last decade, a period when inflation hasn’t been a problem. Indeed, it’s no higher than it was in February.\nEither market players remain confident that the Federal Reserve can keep rising prices under control, or they’re worried the economy won’t keep growing fast enough to push inflation numbers higher. Those concerns are definitely increasing as the delta variant shows its ability to slow economic reopening.\nOur dashboard of indicators aims to add clarity to this debate. Inflation is a complex phenomenon that grows from many places. These 35 key measures offer up a more nuanced picture of how markets are positioned, what the official data say and what consumers and businesses are discounting. Numbers are current as of Monday, July 19 and will be updated weekly.\nFlashing alarmingly bright are the official data, as well as surveys of businesses and consumers. The latest survey by the National Federation of Independent Business, of prices paid by small companies, is at a level it last reached all the way back in the first quarter of 1981. Yet showing no concern at all are market indicators and Bloomberg’s surveys of expert economists’ predictions. Both are below their averages for the last decade.\nResolution should come in two categories that remain finely balanced: prices and wages. These factors drove inflation higher in the 1970s and could do so again. Prices of futures for oil, agriculture and metals have all given up ground after rising very sharply from last year’s lows. But the raw industrials index, which includes basic commodities that aren’t in the futures markets, continues to rise and is nearing its historic top from more than a decade ago.\nMeanwhile, although wage growth remains well within its recent ranges, the pay of low-skilled workers is picking up and employers are complaining that they cannot fill jobs, which could imply wage inflation ahead. The decisive factor could be if a new pandemic-related downturn weakens demand, as well as the hand of labor, again. That would be bad news, but at least it would avert an extended bout of inflation.\nJune’s inflation data delivered a third nasty shock in succession. The Fed’s preferred measure of inflation, the Core PCE deflator, is also at its highest level since 1992. Meanwhile, headline inflation (including fuel and food) is at 5% for the first time since the oil price spike of 2008. Producer price inflation is also high. These are sudden moves and the more muted rise in the “trimmed mean” measure, which excludes goods that have suffered the most extreme changes in price, suggests that it is indeed mainly a transitory effect from the pandemic. But it will still be a relief if next month’s data can show a significant retreat in some of the sectors that were hit by extreme inflation.\nThere is deepening concern over shelter inflation, the single biggest component of the CPI index, which is now up to 2.3% and will likely rise further as higher house prices pull up rents in their wake. This will be particularly closely watched. But the most extreme transitory effects of the pandemic are otherwise beginning to ease. Car rental prices, for example, are now “only” 88% higher than they were 12 months ago, having previously topped 100%. Several sectors which suffered a deflationary blow from the pandemic are still not seeing prices recover. Recreation inflation is still negative. And — heaven be praised — college-tuition inflation remains close to its lowest since records began in 1979, although it did tick up slightly in June. It is still just about possible to sustain an optimistic narrative that the pandemic caused extraordinary inflation in some pockets of the economy but might have brought sanity to others where prices had grown prohibitive.\nThe bond market, where traders make their most precise predictions of inflation, has been in flux all year. Four months ago, 5-year breakevens topped 2.75%, virtually matching their high during the 2008 oil price spike. Since then they have dropped below 2.4%, although the latest data returned them to 2.6% — higher than they were at any point between 2010 and 2020. Meanwhile, expectations for the years from 2026 to 2031 have fallen to 2.16%, suggesting confidence that the Fed will be able to rein in inflation over the next five years. The heat map is based on the 20-day moving average of the breakevens, to avoid being too affected by day-to-day movements, which have been violent in the last few weeks. Nobody is positioned for the Fed to lose control of inflation anytime soon, nor for Germany or Japan to snap out of their disinflationary malaise.\nThese numbers offer perhaps the greatest support for the case that inflation is a near and present danger. All are way above their ranges for the last decade. The small business survey shows inflation expectations at their highest in four decades, while the Institute for Supply Management numbers are at post-2008 highs and still rising in the latest number produced at the beginning of July — although the survey for the services sector did show a slight decline. Consumer expectations have also risen very sharply, to their highest since the commodity price spike before the financial crisis, with the latest Conference Board survey reaching a fresh high for this cycle. This could be transitory but, if so, the numbers need to come down soon.\n\nRising commodity prices represent exactly the kind of inflation that can attack living standards. But, given the economic collapse a year ago and the rush by speculators to get a leveraged play on the rebound, they don’t give firm evidence of inflation that is more than transitory. Metals prices are about 6% below their May peak, while energy prices have also dropped by about 6% as the OPEC+ cartel tries to sort out its problems; it’s not at all clear the latter are locked into an inflationary expansion. One increasingly ominous warning sign comes from the Commodities Research Board raw industrials index, which covers basic commodities that aren’t in the futures market. In theory, these prices should be driven by supply-and-demand dynamics in the real world, not by ebbs and flows of emotion in the markets. The index has gained more than 50% in a year and is nearing an all-time high.\n\nWage inflation is a crucial driver of inflation and, from the official data, it appears to be under control despite a number of factors that would normally drive salaries and wages upwards. Most measures of wage inflation are running below their average for the last five years, with the Atlanta Fed putting overall wage growth at 3.2%. Yet, job vacancies are at an all-time record, while small businesses complain that they have never found it harder to recruit workers. This suggests a problem with skill mismatches coming out of the recession. At the same time, while average hourly earnings have been quite variable over the last few months, the latest number shows them increasing at the fastest rate since 2009. The ongoing wage tracker kept by the Atlanta Fed shows that wage inflation for low-skilled workers has reached 3.6%, close to its highest since the global financial crisis. The National Federation of Independent Business finds the highest proportion of its members raising pay since they started asking the question in 1984.\n\nBroadly, the consensus is that the Fed, like other central banks, will get what it wants. The Fed is forecasting Core PCE (personal consumption expenditure) of 3% for this year but expects it to decline to 2% in 2023; in other words, it will be transitory. The experts are less anxious for now and think it will reach 2.5% this year and decline in the two following years — more or less perfect for the Fed, which is prepared to let inflation “run hot.” German inflation, after a bobble this year, is expected to fall back to 1.7% in 2023; there’s no sign of a new reflationary cycle there or in Japan, or even China. Whatever markets say, the experts are still more worried about deflation.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":659,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173761340,"gmtCreate":1626687771980,"gmtModify":1633924930335,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Inflation worries ahead ....","listText":"Inflation worries ahead ....","text":"Inflation worries ahead ....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/173761340","repostId":"1111084715","repostType":4,"isVote":1,"tweetType":1,"viewCount":788,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179152166,"gmtCreate":1626495851555,"gmtModify":1633926228333,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Yeah true[笑哭]&nbsp;","listText":"Yeah true[笑哭]&nbsp;","text":"Yeah true[笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/179152166","repostId":"2152485685","repostType":4,"repost":{"id":"2152485685","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626481445,"share":"https://ttm.financial/m/news/2152485685?lang=&edition=full","pubTime":"2021-07-17 08:24","market":"us","language":"en","title":"U.S. to allow temporary rise in impurities in anti-smoking drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2152485685","media":"Reuters","summary":"July 16 (Reuters) - The U.S. drug regulator said on Friday it will temporarily allow manufacturers t","content":"<p>July 16 (Reuters) - The U.S. drug regulator said on Friday it will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer Inc halted distribution of its Chantix branded varenicline.</p>\n<p>Pfizer in June halted distribution of Chantix and recalled a number of lots after finding elevated levels of nitrosamines in the pills.</p>\n<p>On Friday, it recalled 12 more lots.</p>\n<p>The Food and Drug Administration (FDA) will temporarily allow some manufacturers to distribute varenicline containing impurities above its intake limit of 37 nanograms per day, but below an interim limit of 185 ng per day, until the impurity can be eliminated or reduced to acceptable levels.</p>\n<p>The regulator said the health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity in varenicline.</p>\n<p>Canadian generic drugmaker Apotex will be temporarily allowed to distribute Apo-Varenicline tablets in the United States to help maintain adequate varenicline supply in the country for the near term, the FDA said.</p>\n<p>The nitrosamine impurity, called N-nitroso-varenicline, may be associated with a potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication, the FDA said.</p>\n<p>Risk of exposure to the carcinogen at interim acceptable intake levels up to 185 ng per day presents minimal additional cancer risk, compared with a lifetime exposure at the 37 ng per day level, the agency said.</p>\n<p>The FDA determined that varenicline recalled by Pfizer poses an unnecessary risk to patients and recommended healthcare professionals to consider other available treatment options.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. to allow temporary rise in impurities in anti-smoking drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. to allow temporary rise in impurities in anti-smoking drug\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-17 08:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 16 (Reuters) - The U.S. drug regulator said on Friday it will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer Inc halted distribution of its Chantix branded varenicline.</p>\n<p>Pfizer in June halted distribution of Chantix and recalled a number of lots after finding elevated levels of nitrosamines in the pills.</p>\n<p>On Friday, it recalled 12 more lots.</p>\n<p>The Food and Drug Administration (FDA) will temporarily allow some manufacturers to distribute varenicline containing impurities above its intake limit of 37 nanograms per day, but below an interim limit of 185 ng per day, until the impurity can be eliminated or reduced to acceptable levels.</p>\n<p>The regulator said the health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity in varenicline.</p>\n<p>Canadian generic drugmaker Apotex will be temporarily allowed to distribute Apo-Varenicline tablets in the United States to help maintain adequate varenicline supply in the country for the near term, the FDA said.</p>\n<p>The nitrosamine impurity, called N-nitroso-varenicline, may be associated with a potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication, the FDA said.</p>\n<p>Risk of exposure to the carcinogen at interim acceptable intake levels up to 185 ng per day presents minimal additional cancer risk, compared with a lifetime exposure at the 37 ng per day level, the agency said.</p>\n<p>The FDA determined that varenicline recalled by Pfizer poses an unnecessary risk to patients and recommended healthcare professionals to consider other available treatment options.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152485685","content_text":"July 16 (Reuters) - The U.S. drug regulator said on Friday it will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer Inc halted distribution of its Chantix branded varenicline.\nPfizer in June halted distribution of Chantix and recalled a number of lots after finding elevated levels of nitrosamines in the pills.\nOn Friday, it recalled 12 more lots.\nThe Food and Drug Administration (FDA) will temporarily allow some manufacturers to distribute varenicline containing impurities above its intake limit of 37 nanograms per day, but below an interim limit of 185 ng per day, until the impurity can be eliminated or reduced to acceptable levels.\nThe regulator said the health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity in varenicline.\nCanadian generic drugmaker Apotex will be temporarily allowed to distribute Apo-Varenicline tablets in the United States to help maintain adequate varenicline supply in the country for the near term, the FDA said.\nThe nitrosamine impurity, called N-nitroso-varenicline, may be associated with a potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication, the FDA said.\nRisk of exposure to the carcinogen at interim acceptable intake levels up to 185 ng per day presents minimal additional cancer risk, compared with a lifetime exposure at the 37 ng per day level, the agency said.\nThe FDA determined that varenicline recalled by Pfizer poses an unnecessary risk to patients and recommended healthcare professionals to consider other available treatment options.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":936,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":179152024,"gmtCreate":1626495809968,"gmtModify":1633926228580,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Will it affect share price","listText":"Will it affect share price","text":"Will it affect share price","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/179152024","repostId":"2152168563","repostType":4,"repost":{"id":"2152168563","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1626489317,"share":"https://ttm.financial/m/news/2152168563?lang=&edition=full","pubTime":"2021-07-17 10:35","market":"us","language":"en","title":"Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content","url":"https://stock-news.laohu8.com/highlight/detail?id=2152168563","media":"T-Reuters","summary":"Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lo","content":"<p>Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use &amp; Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-07-17 10:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use &amp; Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152168563","content_text":"Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use & Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1016,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170711238,"gmtCreate":1626450734324,"gmtModify":1633926599101,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Should have more details","listText":"Should have more details","text":"Should have more details","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170711238","repostId":"1140939614","repostType":4,"isVote":1,"tweetType":1,"viewCount":816,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170719296,"gmtCreate":1626450627215,"gmtModify":1633926600145,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Nice to read article","listText":"Nice to read article","text":"Nice to read article","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170719296","repostId":"1120221325","repostType":4,"isVote":1,"tweetType":1,"viewCount":815,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":897077805,"gmtCreate":1628865581207,"gmtModify":1631884033650,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Lemonade go for&nbsp; it","listText":"Lemonade go for&nbsp; it","text":"Lemonade go for it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/897077805","repostId":"2159291893","repostType":4,"repost":{"id":"2159291893","kind":"highlight","pubTimestamp":1628864400,"share":"https://ttm.financial/m/news/2159291893?lang=&edition=full","pubTime":"2021-08-13 22:20","market":"us","language":"en","title":"2 Tech Stocks With 96% to 140% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2159291893","media":"Motley Fool","summary":"Analysts see big gains for Coinbase and Lemonade shareholders.","content":"<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.</p>\n<p>With that in mind, Wall Street analysts see significant upside for&nbsp;<b>Coinbase Global</b> (NASDAQ:COIN) and&nbsp;<b>Lemonade</b> (NYSE:LMND). Let's look at both of these tech stocks.</p>\n<h2>Coinbase Global: 140% implied upside</h2>\n<p>Coinbase helps its clients participate in the cryptoeconomy. Its platform offers a range&nbsp;of products to 68 million&nbsp;users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.</p>\n<p>For instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.</p>\n<p>As of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2%&nbsp;of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson&nbsp;value Coinbase stock at $650 per share, a 140% premium to its current price.</p>\n<p>Financially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees&nbsp;comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price&nbsp;of <b>bitcoin</b> and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2020 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Monthly transacting users</p></td>\n   <td width=\"156\"><p>1.5 million</p></td>\n   <td width=\"156\"><p>8.8 million</p></td>\n   <td width=\"156\"><p>487%</p></td>\n  </tr>\n  <tr>\n   <td width=\"156\"><p>Revenue</p></td>\n   <td width=\"156\"><p>$633.8 million</p></td>\n   <td width=\"156\"><p>$4.9 billion</p></td>\n   <td width=\"156\"><p>678%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Coinbase&nbsp;SEC filings. TTM&nbsp;= trailing-12-months. CAGR&nbsp;= compound annual growth rates.</p>\n<p>Before buying Coinbase stock, investors should ask themselves <a href=\"https://laohu8.com/S/AONE.U\">one</a> question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.</p>\n<h2>Lemonade: 96% implied upside</h2>\n<p>Lemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.</p>\n<p>This differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built&nbsp;to collect and deploy the types of data captured by Lemonade.</p>\n<p>This advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler&nbsp;value Lemonade at $163 per share, representing 96% upside compared to its current price.</p>\n<p>Investors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2019 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Customers</p></td>\n   <td width=\"156\"><p>442,752</p></td>\n   <td width=\"156\"><p>1.2 million</p></td>\n   <td width=\"156\"><p>65%</p></td>\n  </tr>\n  <tr>\n   <td width=\"156\"><p>Gross profit</p></td>\n   <td width=\"156\"><p>$5.7 million</p></td>\n   <td width=\"156\"><p>$26.5 million</p></td>\n   <td width=\"156\"><p>116%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.</p>\n<p>Looking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Tech Stocks With 96% to 140% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Tech Stocks With 96% to 140% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 22:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LMND":"Lemonade, Inc.","COIN":"Coinbase Global, Inc."},"source_url":"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159291893","content_text":"As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.\nWith that in mind, Wall Street analysts see significant upside for Coinbase Global (NASDAQ:COIN) and Lemonade (NYSE:LMND). Let's look at both of these tech stocks.\nCoinbase Global: 140% implied upside\nCoinbase helps its clients participate in the cryptoeconomy. Its platform offers a range of products to 68 million users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.\nFor instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.\nAs of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2% of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson value Coinbase stock at $650 per share, a 140% premium to its current price.\nFinancially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price of bitcoin and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.\n\n\n\nMetric\nQ2 2020 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nMonthly transacting users\n1.5 million\n8.8 million\n487%\n\n\nRevenue\n$633.8 million\n$4.9 billion\n678%\n\n\n\nData source: Coinbase SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rates.\nBefore buying Coinbase stock, investors should ask themselves one question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.\nLemonade: 96% implied upside\nLemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.\nThis differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built to collect and deploy the types of data captured by Lemonade.\nThis advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler value Lemonade at $163 per share, representing 96% upside compared to its current price.\nInvestors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.\n\n\n\nMetric\nQ2 2019 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nCustomers\n442,752\n1.2 million\n65%\n\n\nGross profit\n$5.7 million\n$26.5 million\n116%\n\n\n\nData source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.\nLooking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.","news_type":1,"symbols_score_info":{"COIN":0.9,"LMND":0.9}},"isVote":1,"tweetType":1,"viewCount":781,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179152166,"gmtCreate":1626495851555,"gmtModify":1633926228333,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Yeah true[笑哭]&nbsp;","listText":"Yeah true[笑哭]&nbsp;","text":"Yeah true[笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/179152166","repostId":"2152485685","repostType":4,"repost":{"id":"2152485685","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626481445,"share":"https://ttm.financial/m/news/2152485685?lang=&edition=full","pubTime":"2021-07-17 08:24","market":"us","language":"en","title":"U.S. to allow temporary rise in impurities in anti-smoking drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2152485685","media":"Reuters","summary":"July 16 (Reuters) - The U.S. drug regulator said on Friday it will temporarily allow manufacturers t","content":"<p>July 16 (Reuters) - The U.S. drug regulator said on Friday it will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer Inc halted distribution of its Chantix branded varenicline.</p>\n<p>Pfizer in June halted distribution of Chantix and recalled a number of lots after finding elevated levels of nitrosamines in the pills.</p>\n<p>On Friday, it recalled 12 more lots.</p>\n<p>The Food and Drug Administration (FDA) will temporarily allow some manufacturers to distribute varenicline containing impurities above its intake limit of 37 nanograms per day, but below an interim limit of 185 ng per day, until the impurity can be eliminated or reduced to acceptable levels.</p>\n<p>The regulator said the health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity in varenicline.</p>\n<p>Canadian generic drugmaker Apotex will be temporarily allowed to distribute Apo-Varenicline tablets in the United States to help maintain adequate varenicline supply in the country for the near term, the FDA said.</p>\n<p>The nitrosamine impurity, called N-nitroso-varenicline, may be associated with a potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication, the FDA said.</p>\n<p>Risk of exposure to the carcinogen at interim acceptable intake levels up to 185 ng per day presents minimal additional cancer risk, compared with a lifetime exposure at the 37 ng per day level, the agency said.</p>\n<p>The FDA determined that varenicline recalled by Pfizer poses an unnecessary risk to patients and recommended healthcare professionals to consider other available treatment options.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. to allow temporary rise in impurities in anti-smoking drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. to allow temporary rise in impurities in anti-smoking drug\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-17 08:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 16 (Reuters) - The U.S. drug regulator said on Friday it will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer Inc halted distribution of its Chantix branded varenicline.</p>\n<p>Pfizer in June halted distribution of Chantix and recalled a number of lots after finding elevated levels of nitrosamines in the pills.</p>\n<p>On Friday, it recalled 12 more lots.</p>\n<p>The Food and Drug Administration (FDA) will temporarily allow some manufacturers to distribute varenicline containing impurities above its intake limit of 37 nanograms per day, but below an interim limit of 185 ng per day, until the impurity can be eliminated or reduced to acceptable levels.</p>\n<p>The regulator said the health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity in varenicline.</p>\n<p>Canadian generic drugmaker Apotex will be temporarily allowed to distribute Apo-Varenicline tablets in the United States to help maintain adequate varenicline supply in the country for the near term, the FDA said.</p>\n<p>The nitrosamine impurity, called N-nitroso-varenicline, may be associated with a potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication, the FDA said.</p>\n<p>Risk of exposure to the carcinogen at interim acceptable intake levels up to 185 ng per day presents minimal additional cancer risk, compared with a lifetime exposure at the 37 ng per day level, the agency said.</p>\n<p>The FDA determined that varenicline recalled by Pfizer poses an unnecessary risk to patients and recommended healthcare professionals to consider other available treatment options.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152485685","content_text":"July 16 (Reuters) - The U.S. drug regulator said on Friday it will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer Inc halted distribution of its Chantix branded varenicline.\nPfizer in June halted distribution of Chantix and recalled a number of lots after finding elevated levels of nitrosamines in the pills.\nOn Friday, it recalled 12 more lots.\nThe Food and Drug Administration (FDA) will temporarily allow some manufacturers to distribute varenicline containing impurities above its intake limit of 37 nanograms per day, but below an interim limit of 185 ng per day, until the impurity can be eliminated or reduced to acceptable levels.\nThe regulator said the health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity in varenicline.\nCanadian generic drugmaker Apotex will be temporarily allowed to distribute Apo-Varenicline tablets in the United States to help maintain adequate varenicline supply in the country for the near term, the FDA said.\nThe nitrosamine impurity, called N-nitroso-varenicline, may be associated with a potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication, the FDA said.\nRisk of exposure to the carcinogen at interim acceptable intake levels up to 185 ng per day presents minimal additional cancer risk, compared with a lifetime exposure at the 37 ng per day level, the agency said.\nThe FDA determined that varenicline recalled by Pfizer poses an unnecessary risk to patients and recommended healthcare professionals to consider other available treatment options.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":936,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":806845452,"gmtCreate":1627651505676,"gmtModify":1633757435529,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Too expensive","listText":"Too expensive","text":"Too expensive","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806845452","repostId":"1161272388","repostType":4,"repost":{"id":"1161272388","kind":"news","pubTimestamp":1627644776,"share":"https://ttm.financial/m/news/1161272388?lang=&edition=full","pubTime":"2021-07-30 19:32","market":"us","language":"en","title":"Wall Street analysts react to Amazon’s disappointing second-quarter earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1161272388","media":"CNBC","summary":"Amazon reported another massive quarter on Thursday, but it wasn’t enough to meet sky-high expectations, leading Wall Street analysts to scale back their estimates.The tech giant reported $15.12 in earnings per share and $113.08 billion in revenue for its second quarter. That topped expectations of $12.30 in earnings but missed the projected $115.2 billion in revenue, according to analysts surveyed by Refinitiv.Following the report, Morgan Stanley’s Brian Nowak cut his price target for the stock","content":"<div>\n<p>Amazon reported another massive quarter on Thursday, but it wasn’t enough to meet sky-high expectations, leading Wall Street analysts to scale back their estimates.\nThe tech giant reported $15.12 in ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/30/amazon-earnings-wall-street-analysts-react.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street analysts react to Amazon’s disappointing second-quarter earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street analysts react to Amazon’s disappointing second-quarter earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-30 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/30/amazon-earnings-wall-street-analysts-react.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amazon reported another massive quarter on Thursday, but it wasn’t enough to meet sky-high expectations, leading Wall Street analysts to scale back their estimates.\nThe tech giant reported $15.12 in ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/30/amazon-earnings-wall-street-analysts-react.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://www.cnbc.com/2021/07/30/amazon-earnings-wall-street-analysts-react.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1161272388","content_text":"Amazon reported another massive quarter on Thursday, but it wasn’t enough to meet sky-high expectations, leading Wall Street analysts to scale back their estimates.\nThe tech giant reported $15.12 in earnings per share and $113.08 billion in revenue for its second quarter. That topped expectations of $12.30 in earnings but missed the projected $115.2 billion in revenue, according to analysts surveyed by Refinitiv.\nFollowing the report, Morgan Stanley’s Brian Nowak cut his price target for the stock to $4,300 per share from $4,500, citing the potential for some near-term weakness. However, Nowak did keep his overweight rating on the stock and said the long-term outlook was strong.\nAmazon closed Thursday at $3,599.92, off 0.8% for the session, and fell another 6.3% in premarket trading Friday.\n“AMZN’s slower than expected retail revenue growth and lower profitability (from surging investment) send estimates lower today. Over the long-term we see these investments leading to deeper core retail and AWS moats (why we remain bullish),” the Morgan Stanley note said.\nSimilarly, UBS analyst Michael Lasser lowered his price target on Amazon to $4,020 per share from $4,350 but reiterated his buy rating.\n“In the past, it’s been prudent to accumulate AMZN’s shares when they pull back in response to an investment cycle. We think it would be shrewd to do the same now. We are moderating our EPS [estimates] due to slightly lower NT rev assumptions & ongoing investments in fulfillment. But, these should payoff over the long-run,” the UBS note said.\nHere’s what analysts said about Amazon earnings:\nAtlantic Equities - Overweight, price target to $3,800 from $4,000\n\n “Q2 revenue missed and Q3 revenue and op profit guidance were below consensus as reopenings slowed Amazon’s sales growth more than anticipated, with the lower top line reducing leverage. On the flipside, AWS delivered an impressive acceleration and advertising topped expectations, and with both these key profit drivers remaining strong we continue to see attractive profit growth in 2022, albeit are reducing our projections slightly.”\n\nMizuho - Buy, price target to $4,100 from $4,400\n\n “With expectations being reset, we are lowering FY23 EBITDA by 6% to $130bn and PT from $4,400 to $4,100, but we feel 3Q21 revenue guidance could be conservative due to the return of back-to-school. We remain positive on AMZN long-term, and believe its valuation is attractive at 13x FY23 EBITDA compared to 30% CAGR.”\n\nBarclays - Overweight, price target to $4,130 from $4,300\n\n “AMZN reported revenue and OI that were 2% and 1% below consensus and guided 3Q below. This kind of miss is a rare occurrence for a high quality name like AMZN, but forecasting the back side of the pandemic surge is proving challenging for many companies, and despite the deceleration, AMZN continues to add prime members and gain e-commerce share. This print won’t derail the long-term bull case around AWS and retail, but likely means we are range bound for the next few months until a catalyst emerges.”\n\nBank of America - Buy, price target to $4,250 from $4,350\n\n “We think results suggest bigger slowdown in May/June Online retail spend than expected (negative read for eBay/Wayfair), while 3Q revenue guidance miss partially reflects Street not properly incorporating Prime Day shift impact on 3Q. ... . Amazon stock was down as much as 7% in AH trading, likely on the disappointing revenue guide and possibly AWS margins, but we think company remains in solid position in industry, with US retail growth above our industry sales.′\n\nEvercore ISI - Outperform, price target to $4,200 from $4,500\n\n “Our long term thesis is intact for Amazon. ... .Tactically, AMZN shares may well be range bound near-term as investors debate whether AMZN can recover to 20% reported Y/Y revenue growth in 2022 – we believe it can, given the size of its TAMs, its new growth initiatives, and its execution track record. Investors will also debate the potential ROI on Amazon’s latest investment cycle – i.e. its declining Operating Margins in H2:21.”\n\nCredit Suisse - Outperform, price target to $4,700 from $4,850\n\n “We maintain our Outperform rating for AMZN shares on the following points: 1) continued e-commerce segment operating margin expansion as Amazon grows into its larger infrastructure, 2) optionality for faster-than-expected FCF growth vis-à-vis its advertising segment, 3) upward bias to AWS revenue forecasts and likely more moderate deceleration path as suggested by ongoing capital intensity and rising performance obligations.”\n\nJPMorgan - Overweight, price target to $4,100 from $4,600\n\n “Slower growth & increased investments make the shares more challenging NT, but we expect revenue growth to normalize more around 20% next year & AMZN’s investments in fulfillment & logistics bode well for future growth, including for AMZL & MCF (multi-channel fulfillment).”\n\nJefferies- Buy, $4,200 price target\n\n “AMZN’s highest margin businesses accelerated once again in 2Q, while core-Retail decelerated from difficult comps and increased mobility. Despite 3Q revenue guidance coming in below consensus, our revised estimates imply core-Retail growth will remain above pre-pandemic levels on a 2-year basis.”\n\nJMP - Market outperform, $4,500 price target\n\n “We acknowledge the concern around decelerating growth as markets reopen and comps get tougher throughout the year. But we also believe that consumer behavior changes toward eCommerce due to the pandemic are lasting and that given the continued health of the consumer (at least domestically), Amazon remains among the best-positioned providers overall. We were encouraged with AWS and Amazon Advertising revenue reaccelerating in the quarter, trends that could continue, and we reiterate our Market Outperform rating and $4,500 price target.”\n\nKeyBanc - Overweight, $4,000 price target\n\n “Amazon.com will have been one of the strongest beneficiaries of COVID driven secular acceleration, but we believe reopening will drive lumpiness in growth rates. Nevertheless, Prime Member spending is still up y/y and overall competitive dynamics remain more favorable than pre-COVID. +37% AWS growth was strong and corporates focusing on growth investments should be a tailwind. We remain OW-rated given strong long-term share (and earnings) opportunities.”\n\nBaird - Outperform, $4,000 price target\n\n “We never like to see a miss, especially after shares outperformed since Q1, but it’s not shocking given choppy Q2 e-commerce checks (keep in mind results were in line with guidance.) What’s more notable, in our view, than the impact of mobility is that each of Amazon’s key (higher margin) services segments beat consensus expectations: AWS, 3P Services, Subscriptions, and Advertising. This is the quasi-recurring model we’ve highlighted as deserving of a higher multiple.”\n\nPiper Sandler - Overweight, price target to $3,904 from $4,000\n\n “Less positive, management noted online shopping behavior has changed with consumers comp-ing last year’s demand plus greater mobility. Management said to expect the pattern of difficult y/y revenue compares to continue for the next several quarters. Further, management alluded to the recent pullforward in demand requiring additional investment to catch up. ... .Essentially, while consumer demand has waned with the pandemic, investment remains elevated.”\n\nStifel - Buy, $4,400 price target\n\n “We now have better visibility into the 2H and estimates are adjusted better reflecting the new normal as we emerge from the pandemic. We believe the setup is attractive now that the shares are on the other side of the COVID comp reset. We would be buyers on the share decline stemming from tonight’s report and maintain our $4,400 price target.”\n\nCowen - Outperform, price target to $4,400 from $4,600\n\n “AMZN’s 2Q21 results were softer than expected, with rev 1.8% below consensus as higher consumer mobility impacted eCommerce demand, muting further acceleration at AWS and adv.; Op Income was also 1% below cons. Meanwhile, 3Q21 rev and Op Inc. guide were below cons. on tougher eCommerce comps & higher fulfillment costs.”\n\nTruist - Buy, price target to $3,800 from $4,000\n\n “2Q21 marks Amazon’s first earnings miss since the start of the pandemic, reflecting a mixed picture of softening demand within its Online Stores segment but sustained strength across AWS, 3P and advertising, which drove improved margins. While ecom demand may be normalizing with the re-opening, we still expect AMZN to put up mid-teens growth against a tough +40% in 2H20, with re-acceleration in FY22.”\n\nOppenheimer - Outperform, price target to $4,200 from $4,400\n\n “While reducing our target to $4,200 from $4,400 on expected slower 2H growth, we are maintaining our Outperform rating, given the prospects for secular gains ahead of AMZN. ... .While slowing in 2Q, growth in high margin segments continued to outpace growth in the overall business, leaving room for profitability upside in 2H.”\n\nGuggenheim - Buy, $4,200 price target\n\n “We continue to believe Amazon is very well positioned for the long term and reiterate our BUY rating and $4,200 price target. We would buy the weakness in the shares.While the company noted a moderation in its year-over-year growth rate during 2Q21 into the mid-teens and the company will continue to be up against difficult top-line comparisons in coming quarters, we continue to see a favorable backdrop for the company and the shares through the balance of 2021 as top-line growth should remain healthy, but decelerating.”\n\nTelsey - Outperform, $4,000 price target\n\n “We understand Amazon shares are likely to trade down, given soft 2Q21 results and a lower 3Q21 outlook. That said, we believe Amazon is executing at a high level and should continue to gain market share by leveraging its sticky customer base, small business relationships, and retail consolidation. The focus on newer businesses and initiatives—grocery, pharmacy, fashion, home, private brands, third-party, same-day/one-day delivery, and Amazon Logistics—is making Amazon more valuable.”\n\nBernstein - Outperform, price target to $4,000 from $4,200\n\n “At some point, when you’re 40% of US eCommerce and7-8% of US retail, it’s harder to create beta beyond overall retail trends. ... The revenue and EBIT guide were also lower than anticipated, reminding everyone that Amazon is still very much a retail-first business.”\n\nNeedham - Buy, $4,150 price target\n\n “AMZN is a services company, not a products company (our view) because Services revs reached 49% of 2Q revs, and we calculate that Services segment profit was $10.7B, which was 4x higher than Product profits in 2Q21. We expect Services revs to be larger than Product revs in 3Q21.”","news_type":1,"symbols_score_info":{"AMZN":0.9}},"isVote":1,"tweetType":1,"viewCount":496,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173761340,"gmtCreate":1626687771980,"gmtModify":1633924930335,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Inflation worries ahead ....","listText":"Inflation worries ahead ....","text":"Inflation worries ahead ....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/173761340","repostId":"1111084715","repostType":4,"isVote":1,"tweetType":1,"viewCount":788,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806846344,"gmtCreate":1627651396688,"gmtModify":1633757437507,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Worrying 😟","listText":"Worrying 😟","text":"Worrying 😟","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806846344","repostId":"2155137729","repostType":4,"repost":{"id":"2155137729","kind":"highlight","pubTimestamp":1627647756,"share":"https://ttm.financial/m/news/2155137729?lang=&edition=full","pubTime":"2021-07-30 20:22","market":"us","language":"en","title":"Goldman Sachs has been super-bullish on the global economy, but not anymore. Here's why.","url":"https://stock-news.laohu8.com/highlight/detail?id=2155137729","media":"MarketWatch","summary":"Goldman Sachs has prided itself on its bullish stance on the global economy, with its above-consensu","content":"<p>Goldman Sachs has prided itself on its bullish stance on the global economy, with its above-consensus takes doing better than many of its banking rivals to forecast just how resilient consumers and businesses have been.</p>\n<p>The gross domestic product data released Thursday show the world's largest economy, the U.S., has already surpassed its pre-pandemic peak in the second quarter.</p>\n<p>But...</p>\n<p>Goldman Sachs economists Daan Struyven and Sid Bhushan explain the bank's economics team has now become less enthusiastic. They've cut economic growth projections for the low-vaccination Asian economies including India and Australia but also the U.S. -- even while upgrading Brazil and Mexico forecasts -- taking their global growth forecast for this year to 6.4%, which is only 0.3% above the Wall Street consensus.</p>\n<p><img src=\"https://static.tigerbbs.com/efafcbb409cc58c4236521501a1f3e8f\" tg-width=\"700\" tg-height=\"341\" width=\"100%\" height=\"auto\"></p>\n<p>The more transmissible delta strain of coronavirus implies a slower recovery because of renewed outbreaks. The issue isn't just government restrictions, but also the choices of individuals to limit high-contact services.</p>\n<p>\"The share of Americans reporting to 'always avoid' high-contact activities has decreased, but remains substantial at around 50% for public transportation and large events, and 30% for travel,\" they said, citing YouGov data. \"A further recovery will require not only rising vaccinations and related medical improvements, but also time for individuals to become more comfortable.\"</p>\n<p><img src=\"https://static.tigerbbs.com/72d09db3e3c3223ebe3f95b0d81180af\" tg-width=\"700\" tg-height=\"465\" width=\"100%\" height=\"auto\"></p>\n<p>And the U.S. is grouped into <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the low-risk aversion countries, based on the restrictions imposed relative to fatalities. \"China's high risk aversion could keep quarantines and travel controls in place for longer, and delay the recovery in tourism economies such as Vietnam, Thailand, and Singapore,\" they say.</p>\n<p>The pessimism comes amid a new report from the Centers for Disease Control and Prevention, arguing the delta variant as as transmissible as chickenpox.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs has been super-bullish on the global economy, but not anymore. Here's why.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs has been super-bullish on the global economy, but not anymore. Here's why.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-30 20:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/goldman-sachs-has-been-super-bullish-on-the-global-economy-but-not-anymore-heres-why-11627641051?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has prided itself on its bullish stance on the global economy, with its above-consensus takes doing better than many of its banking rivals to forecast just how resilient consumers and ...</p>\n\n<a href=\"https://www.marketwatch.com/story/goldman-sachs-has-been-super-bullish-on-the-global-economy-but-not-anymore-heres-why-11627641051?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.marketwatch.com/story/goldman-sachs-has-been-super-bullish-on-the-global-economy-but-not-anymore-heres-why-11627641051?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155137729","content_text":"Goldman Sachs has prided itself on its bullish stance on the global economy, with its above-consensus takes doing better than many of its banking rivals to forecast just how resilient consumers and businesses have been.\nThe gross domestic product data released Thursday show the world's largest economy, the U.S., has already surpassed its pre-pandemic peak in the second quarter.\nBut...\nGoldman Sachs economists Daan Struyven and Sid Bhushan explain the bank's economics team has now become less enthusiastic. They've cut economic growth projections for the low-vaccination Asian economies including India and Australia but also the U.S. -- even while upgrading Brazil and Mexico forecasts -- taking their global growth forecast for this year to 6.4%, which is only 0.3% above the Wall Street consensus.\n\nThe more transmissible delta strain of coronavirus implies a slower recovery because of renewed outbreaks. The issue isn't just government restrictions, but also the choices of individuals to limit high-contact services.\n\"The share of Americans reporting to 'always avoid' high-contact activities has decreased, but remains substantial at around 50% for public transportation and large events, and 30% for travel,\" they said, citing YouGov data. \"A further recovery will require not only rising vaccinations and related medical improvements, but also time for individuals to become more comfortable.\"\n\nAnd the U.S. is grouped into one of the low-risk aversion countries, based on the restrictions imposed relative to fatalities. \"China's high risk aversion could keep quarantines and travel controls in place for longer, and delay the recovery in tourism economies such as Vietnam, Thailand, and Singapore,\" they say.\nThe pessimism comes amid a new report from the Centers for Disease Control and Prevention, arguing the delta variant as as transmissible as chickenpox.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":983,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170719296,"gmtCreate":1626450627215,"gmtModify":1633926600145,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Nice to read article","listText":"Nice to read article","text":"Nice to read article","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170719296","repostId":"1120221325","repostType":4,"isVote":1,"tweetType":1,"viewCount":815,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179152024,"gmtCreate":1626495809968,"gmtModify":1633926228580,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Will it affect share price","listText":"Will it affect share price","text":"Will it affect share price","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/179152024","repostId":"2152168563","repostType":4,"repost":{"id":"2152168563","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1626489317,"share":"https://ttm.financial/m/news/2152168563?lang=&edition=full","pubTime":"2021-07-17 10:35","market":"us","language":"en","title":"Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content","url":"https://stock-news.laohu8.com/highlight/detail?id=2152168563","media":"T-Reuters","summary":"Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lo","content":"<p>Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use &amp; Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-07-17 10:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use &amp; Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152168563","content_text":"Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use & Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1016,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170711238,"gmtCreate":1626450734324,"gmtModify":1633926599101,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Should have more details","listText":"Should have more details","text":"Should have more details","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170711238","repostId":"1140939614","repostType":4,"repost":{"id":"1140939614","kind":"news","pubTimestamp":1626446093,"share":"https://ttm.financial/m/news/1140939614?lang=&edition=full","pubTime":"2021-07-16 22:34","market":"us","language":"en","title":"Dow gives up earlier gain, loses 150 points despite strong retail sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1140939614","media":"CNBC","summary":"The Dow Jones Industrial Average drifted lower Friday even as the latest retail sales numbers came o","content":"<div>\n<p>The Dow Jones Industrial Average drifted lower Friday even as the latest retail sales numbers came out better-than-expected.\nThe Dow lost 150 points, or 0.46%, after opening above 35,000. The index ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/15/stock-market-open-to-close-news.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow gives up earlier gain, loses 150 points despite strong retail sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow gives up earlier gain, loses 150 points despite strong retail sales\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 22:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/15/stock-market-open-to-close-news.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Dow Jones Industrial Average drifted lower Friday even as the latest retail sales numbers came out better-than-expected.\nThe Dow lost 150 points, or 0.46%, after opening above 35,000. The index ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/15/stock-market-open-to-close-news.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.cnbc.com/2021/07/15/stock-market-open-to-close-news.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1140939614","content_text":"The Dow Jones Industrial Average drifted lower Friday even as the latest retail sales numbers came out better-than-expected.\nThe Dow lost 150 points, or 0.46%, after opening above 35,000. The index closed just short of that level on Monday. The S&P 500 dipped around 0.2% and the Nasdaq Composite edged about 0.1% lower.\nRetail and food service salesrose 0.6% in June, while economists surveyed by Dow Jones had expected a 0.4% decline. Excluding autos, those sales jumped 1.3%, beating economists’ estimate of a 0.4% gain.\nWeaker performance from technology stocks weighed on the market. Shares of Netflix fell more than 1% ahead of the streaming giant’s second-quarter earnings report next week. Nvidia shares fell about 2%.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":816,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171713003,"gmtCreate":1626763657102,"gmtModify":1633771248774,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089547899638310","authorIdStr":"4089547899638310"},"themes":[],"htmlText":"Will market crash?","listText":"Will market crash?","text":"Will market crash?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171713003","repostId":"1140799023","repostType":4,"repost":{"id":"1140799023","kind":"news","pubTimestamp":1626759279,"share":"https://ttm.financial/m/news/1140799023?lang=&edition=full","pubTime":"2021-07-20 13:34","market":"hk","language":"en","title":"Inflation Is Here — These 35 Metrics Tell You How Much to Worry","url":"https://stock-news.laohu8.com/highlight/detail?id=1140799023","media":"Bloomberg","summary":"A year ago, the Covid-19 pandemic crushed prices in many parts of the U.S. economy. As expected, tha","content":"<p>A year ago, the Covid-19 pandemic crushed prices in many parts of the U.S. economy. As expected, that has created inflation 12 months on as the economy reopens and rebounds. Now the market seems to believe that a resurgence of the pandemic will rein in inflation before it grows out of control. No one disputes that inflation has arrived. The question is where it’s heading.</p>\n<p>The most basic fact is that June’s “headline” consumer price index, including everything the government puts in its representative basket of products and services that Americans buy, stands at 5.4%, the highest in 30 years barring one month in the summer of 2008 when oil reached nearly $150 per barrel. Exclude food and fuel, always variable, and inflation still comes in at 4.5% — its highest in three decades by far. Even if the most extreme movers both up and down are stripped out, inflation stands at 2.9%, its worst since 1992 (barring a few months of very expensive oil). Those numbers would seem to validate the doomsayers.</p>\n<p>Yet bond markets and economists take the opposite view. They see inflation not only coming under control but eventually falling to levels lower than before the pandemic hit. The bond market’s best estimate of the average inflation rate for the next 10 years stands at 2.3%, which is roughly where it’s been for four months even as other numbers have gotten worse. The yield curve — the extra yield that investors demand for 10-year bonds rather than 2-year bonds, which generally rises when people expect higher inflation — is now below 1%. That’s less than its average for the last decade, a period when inflation hasn’t been a problem. Indeed, it’s no higher than it was in February.</p>\n<p>Either market players remain confident that the Federal Reserve can keep rising prices under control, or they’re worried the economy won’t keep growing fast enough to push inflation numbers higher. Those concerns are definitely increasing as the delta variant shows its ability to slow economic reopening.</p>\n<p>Our dashboard of indicators aims to add clarity to this debate. Inflation is a complex phenomenon that grows from many places. These 35 key measures offer up a more nuanced picture of how markets are positioned, what the official data say and what consumers and businesses are discounting. Numbers are current as of Monday, July 19 and will be updated weekly.</p>\n<p><img src=\"https://static.tigerbbs.com/adee36e07b6919f5636c61bcddc3afcb\" tg-width=\"949\" tg-height=\"678\" referrerpolicy=\"no-referrer\">Flashing alarmingly bright are the official data, as well as surveys of businesses and consumers. The latest survey by the National Federation of Independent Business, of prices paid by small companies, is at a level it last reached all the way back in the first quarter of 1981. Yet showing no concern at all are market indicators and Bloomberg’s surveys of expert economists’ predictions. Both are below their averages for the last decade.</p>\n<p>Resolution should come in two categories that remain finely balanced: prices and wages. These factors drove inflation higher in the 1970s and could do so again. Prices of futures for oil, agriculture and metals have all given up ground after rising very sharply from last year’s lows. But the raw industrials index, which includes basic commodities that aren’t in the futures markets, continues to rise and is nearing its historic top from more than a decade ago.</p>\n<p>Meanwhile, although wage growth remains well within its recent ranges, the pay of low-skilled workers is picking up and employers are complaining that they cannot fill jobs, which could imply wage inflation ahead. The decisive factor could be if a new pandemic-related downturn weakens demand, as well as the hand of labor, again. That would be bad news, but at least it would avert an extended bout of inflation.</p>\n<p><img src=\"https://static.tigerbbs.com/5e71f075b43fcaeb158fd768e81345b8\" tg-width=\"944\" tg-height=\"377\" referrerpolicy=\"no-referrer\">June’s inflation data delivered a third nasty shock in succession. The Fed’s preferred measure of inflation, the Core PCE deflator, is also at its highest level since 1992. Meanwhile, headline inflation (including fuel and food) is at 5% for the first time since the oil price spike of 2008. Producer price inflation is also high. These are sudden moves and the more muted rise in the “trimmed mean” measure, which excludes goods that have suffered the most extreme changes in price, suggests that it is indeed mainly a transitory effect from the pandemic. But it will still be a relief if next month’s data can show a significant retreat in some of the sectors that were hit by extreme inflation.</p>\n<p><img src=\"https://static.tigerbbs.com/03f56e14f20907601eea311f677649c5\" tg-width=\"954\" tg-height=\"371\" referrerpolicy=\"no-referrer\">There is deepening concern over shelter inflation, the single biggest component of the CPI index, which is now up to 2.3% and will likely rise further as higher house prices pull up rents in their wake. This will be particularly closely watched. But the most extreme transitory effects of the pandemic are otherwise beginning to ease. Car rental prices, for example, are now “only” 88% higher than they were 12 months ago, having previously topped 100%.&nbsp;Several sectors which suffered a deflationary blow from the pandemic are still not seeing prices recover. Recreation inflation is still negative. And — heaven be praised — college-tuition inflation remains close to its lowest since records began in 1979, although it did tick up slightly in June. It is still just about possible to sustain an optimistic narrative that the pandemic caused extraordinary inflation in some pockets of the economy but might have brought sanity to others where prices had grown prohibitive.</p>\n<p><img src=\"https://static.tigerbbs.com/eacb4482c44ce01dc5be1582e8932f5a\" tg-width=\"948\" tg-height=\"375\" referrerpolicy=\"no-referrer\">The bond market, where traders make their most precise predictions of inflation, has been in flux all year. Four months ago, 5-year breakevens topped 2.75%, virtually matching their high during the 2008 oil price spike. Since then they have dropped below 2.4%, although the latest data returned them to 2.6% — higher than they were at any point between 2010 and 2020. Meanwhile, expectations for the years from 2026 to 2031 have fallen to 2.16%, suggesting confidence that the Fed will be able to rein in inflation over the next five years. The heat map is based on the 20-day moving average of the breakevens, to avoid being too affected by day-to-day movements, which have been violent in the last few weeks. Nobody is positioned for the Fed to lose control of inflation anytime soon, nor for Germany or Japan to snap out of their disinflationary malaise.</p>\n<p><img src=\"https://static.tigerbbs.com/e052d83b8f96767e4b22170b4455ffd8\" tg-width=\"943\" tg-height=\"373\" referrerpolicy=\"no-referrer\">These numbers offer perhaps the greatest support for the case that inflation is a near and present danger. All are way above their ranges for the last decade. The small business survey shows inflation expectations at their highest in four decades, while the Institute for Supply Management numbers are at post-2008 highs&nbsp;and still rising in the latest number produced at the beginning of July — although the survey for the services sector did show a slight decline. Consumer expectations have also risen very sharply, to their highest since the commodity price spike before the financial crisis, with the latest Conference Board survey reaching a fresh high for this cycle. This could be transitory but, if so, the numbers need to come down soon.</p>\n<p><img src=\"https://static.tigerbbs.com/503a1ccabd574d899752b5acb9d3900b\" tg-width=\"948\" tg-height=\"379\" referrerpolicy=\"no-referrer\"></p>\n<p>Rising commodity prices represent exactly the kind of inflation that can attack living standards. But, given the economic collapse a year ago and the rush by speculators to get a leveraged play on the rebound, they don’t give firm evidence of inflation that is more than transitory. Metals prices are about 6% below their May peak, while energy prices have also dropped by about 6% as the OPEC+ cartel tries to sort out its problems; it’s not at all clear the latter are locked into an inflationary expansion. One increasingly ominous warning sign comes from the Commodities Research Board raw industrials index, which covers basic commodities that aren’t in the futures market. In theory, these prices should be driven by supply-and-demand dynamics in the real world, not by ebbs and flows of emotion in the markets. The index has gained more than 50% in a year and is nearing an all-time high.</p>\n<p><img src=\"https://static.tigerbbs.com/037e6afcf827db9373c9fa59e7d762f7\" tg-width=\"954\" tg-height=\"381\" referrerpolicy=\"no-referrer\"></p>\n<p>Wage inflation is a crucial driver of inflation and, from the official data, it appears to be under control despite a number of factors that would normally drive salaries and wages upwards. Most measures of wage inflation are running below their average for the last five years, with the Atlanta Fed putting overall wage growth at 3.2%. Yet, job vacancies are at an all-time record, while small businesses complain that they have never found it harder to recruit workers. This suggests a problem with skill mismatches coming out of the recession. At the same time, while average hourly earnings have been quite variable over the last few months, the latest number shows them increasing at the fastest rate since 2009. The ongoing wage tracker kept by the Atlanta Fed shows that wage inflation for low-skilled workers has reached 3.6%, close to its highest since the global financial crisis. The National Federation of Independent Business finds the highest proportion of its members raising pay since they started asking the question in 1984.</p>\n<p><img src=\"https://static.tigerbbs.com/fbee8b94aaefef4fa3e232c198af27cd\" tg-width=\"951\" tg-height=\"394\" referrerpolicy=\"no-referrer\"></p>\n<p>Broadly, the consensus is that the Fed, like other central banks, will get what it wants. The Fed is forecasting Core PCE (personal consumption expenditure) of 3% for this year but expects it to decline to 2% in 2023; in other words, it will be transitory. The experts are less anxious for now and think it will reach 2.5% this year and decline in the two following years — more or less perfect for the Fed, which is prepared to let inflation “run hot.” German inflation, after a bobble this year, is expected to fall back to 1.7% in 2023; there’s no sign of a new reflationary cycle there or in Japan, or even China. Whatever markets say, the experts are still more worried about deflation.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inflation Is Here — These 35 Metrics Tell You How Much to Worry</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInflation Is Here — These 35 Metrics Tell You How Much to Worry\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-20 13:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/graphics/opinion-authers-inflation-tracker/?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A year ago, the Covid-19 pandemic crushed prices in many parts of the U.S. economy. As expected, that has created inflation 12 months on as the economy reopens and rebounds. Now the market seems to ...</p>\n\n<a href=\"https://www.bloomberg.com/graphics/opinion-authers-inflation-tracker/?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.bloomberg.com/graphics/opinion-authers-inflation-tracker/?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140799023","content_text":"A year ago, the Covid-19 pandemic crushed prices in many parts of the U.S. economy. As expected, that has created inflation 12 months on as the economy reopens and rebounds. Now the market seems to believe that a resurgence of the pandemic will rein in inflation before it grows out of control. No one disputes that inflation has arrived. The question is where it’s heading.\nThe most basic fact is that June’s “headline” consumer price index, including everything the government puts in its representative basket of products and services that Americans buy, stands at 5.4%, the highest in 30 years barring one month in the summer of 2008 when oil reached nearly $150 per barrel. Exclude food and fuel, always variable, and inflation still comes in at 4.5% — its highest in three decades by far. Even if the most extreme movers both up and down are stripped out, inflation stands at 2.9%, its worst since 1992 (barring a few months of very expensive oil). Those numbers would seem to validate the doomsayers.\nYet bond markets and economists take the opposite view. They see inflation not only coming under control but eventually falling to levels lower than before the pandemic hit. The bond market’s best estimate of the average inflation rate for the next 10 years stands at 2.3%, which is roughly where it’s been for four months even as other numbers have gotten worse. The yield curve — the extra yield that investors demand for 10-year bonds rather than 2-year bonds, which generally rises when people expect higher inflation — is now below 1%. That’s less than its average for the last decade, a period when inflation hasn’t been a problem. Indeed, it’s no higher than it was in February.\nEither market players remain confident that the Federal Reserve can keep rising prices under control, or they’re worried the economy won’t keep growing fast enough to push inflation numbers higher. Those concerns are definitely increasing as the delta variant shows its ability to slow economic reopening.\nOur dashboard of indicators aims to add clarity to this debate. Inflation is a complex phenomenon that grows from many places. These 35 key measures offer up a more nuanced picture of how markets are positioned, what the official data say and what consumers and businesses are discounting. Numbers are current as of Monday, July 19 and will be updated weekly.\nFlashing alarmingly bright are the official data, as well as surveys of businesses and consumers. The latest survey by the National Federation of Independent Business, of prices paid by small companies, is at a level it last reached all the way back in the first quarter of 1981. Yet showing no concern at all are market indicators and Bloomberg’s surveys of expert economists’ predictions. Both are below their averages for the last decade.\nResolution should come in two categories that remain finely balanced: prices and wages. These factors drove inflation higher in the 1970s and could do so again. Prices of futures for oil, agriculture and metals have all given up ground after rising very sharply from last year’s lows. But the raw industrials index, which includes basic commodities that aren’t in the futures markets, continues to rise and is nearing its historic top from more than a decade ago.\nMeanwhile, although wage growth remains well within its recent ranges, the pay of low-skilled workers is picking up and employers are complaining that they cannot fill jobs, which could imply wage inflation ahead. The decisive factor could be if a new pandemic-related downturn weakens demand, as well as the hand of labor, again. That would be bad news, but at least it would avert an extended bout of inflation.\nJune’s inflation data delivered a third nasty shock in succession. The Fed’s preferred measure of inflation, the Core PCE deflator, is also at its highest level since 1992. Meanwhile, headline inflation (including fuel and food) is at 5% for the first time since the oil price spike of 2008. Producer price inflation is also high. These are sudden moves and the more muted rise in the “trimmed mean” measure, which excludes goods that have suffered the most extreme changes in price, suggests that it is indeed mainly a transitory effect from the pandemic. But it will still be a relief if next month’s data can show a significant retreat in some of the sectors that were hit by extreme inflation.\nThere is deepening concern over shelter inflation, the single biggest component of the CPI index, which is now up to 2.3% and will likely rise further as higher house prices pull up rents in their wake. This will be particularly closely watched. But the most extreme transitory effects of the pandemic are otherwise beginning to ease. Car rental prices, for example, are now “only” 88% higher than they were 12 months ago, having previously topped 100%. Several sectors which suffered a deflationary blow from the pandemic are still not seeing prices recover. Recreation inflation is still negative. And — heaven be praised — college-tuition inflation remains close to its lowest since records began in 1979, although it did tick up slightly in June. It is still just about possible to sustain an optimistic narrative that the pandemic caused extraordinary inflation in some pockets of the economy but might have brought sanity to others where prices had grown prohibitive.\nThe bond market, where traders make their most precise predictions of inflation, has been in flux all year. Four months ago, 5-year breakevens topped 2.75%, virtually matching their high during the 2008 oil price spike. Since then they have dropped below 2.4%, although the latest data returned them to 2.6% — higher than they were at any point between 2010 and 2020. Meanwhile, expectations for the years from 2026 to 2031 have fallen to 2.16%, suggesting confidence that the Fed will be able to rein in inflation over the next five years. The heat map is based on the 20-day moving average of the breakevens, to avoid being too affected by day-to-day movements, which have been violent in the last few weeks. Nobody is positioned for the Fed to lose control of inflation anytime soon, nor for Germany or Japan to snap out of their disinflationary malaise.\nThese numbers offer perhaps the greatest support for the case that inflation is a near and present danger. All are way above their ranges for the last decade. The small business survey shows inflation expectations at their highest in four decades, while the Institute for Supply Management numbers are at post-2008 highs and still rising in the latest number produced at the beginning of July — although the survey for the services sector did show a slight decline. Consumer expectations have also risen very sharply, to their highest since the commodity price spike before the financial crisis, with the latest Conference Board survey reaching a fresh high for this cycle. This could be transitory but, if so, the numbers need to come down soon.\n\nRising commodity prices represent exactly the kind of inflation that can attack living standards. But, given the economic collapse a year ago and the rush by speculators to get a leveraged play on the rebound, they don’t give firm evidence of inflation that is more than transitory. Metals prices are about 6% below their May peak, while energy prices have also dropped by about 6% as the OPEC+ cartel tries to sort out its problems; it’s not at all clear the latter are locked into an inflationary expansion. One increasingly ominous warning sign comes from the Commodities Research Board raw industrials index, which covers basic commodities that aren’t in the futures market. In theory, these prices should be driven by supply-and-demand dynamics in the real world, not by ebbs and flows of emotion in the markets. The index has gained more than 50% in a year and is nearing an all-time high.\n\nWage inflation is a crucial driver of inflation and, from the official data, it appears to be under control despite a number of factors that would normally drive salaries and wages upwards. Most measures of wage inflation are running below their average for the last five years, with the Atlanta Fed putting overall wage growth at 3.2%. Yet, job vacancies are at an all-time record, while small businesses complain that they have never found it harder to recruit workers. This suggests a problem with skill mismatches coming out of the recession. At the same time, while average hourly earnings have been quite variable over the last few months, the latest number shows them increasing at the fastest rate since 2009. The ongoing wage tracker kept by the Atlanta Fed shows that wage inflation for low-skilled workers has reached 3.6%, close to its highest since the global financial crisis. The National Federation of Independent Business finds the highest proportion of its members raising pay since they started asking the question in 1984.\n\nBroadly, the consensus is that the Fed, like other central banks, will get what it wants. The Fed is forecasting Core PCE (personal consumption expenditure) of 3% for this year but expects it to decline to 2% in 2023; in other words, it will be transitory. The experts are less anxious for now and think it will reach 2.5% this year and decline in the two following years — more or less perfect for the Fed, which is prepared to let inflation “run hot.” German inflation, after a bobble this year, is expected to fall back to 1.7% in 2023; there’s no sign of a new reflationary cycle there or in Japan, or even China. Whatever markets say, the experts are still more worried about deflation.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":659,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}